Skip to content
The GLP-1 Verdict
Menu
Ranked #16 · Grade B+

Ro review

A heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.

Visit Ro Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Multi-state
Brand-name
Yes

The scorecard

Ro scored on our six published factors. See the methodology.

Real-world results89/100
Price honesty80/100
Prescriber access90/100
Formulary choice92/100
Cancellation fairness86/100
Member support88/100

What we like

  • Brand-name (Wegovy/Zepbound) access and insurance support
  • Oral options
  • Polished, well-funded platform

The caveats

  • Does not publicly disclose compounded pricing up front
  • Premium positioning

The verdict

Best for: Patients who want a big, brand-name-capable platform and insurance navigation. A heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.

Ranked #16 of 509 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, our #1 pick. On the board it sits between Curex, 87/100 above and yourEra at 84/100 below, with the Strut Health ruling the next one down.

A grade B+ is a ranking, not an instruction to stop looking: the closest rivals to Ro are ruled on the identical rubric, so the comparison is like for like. We have also ruled on it directly: CoreAge Rx vs Ro goes to CoreAge Rx, 94/100 to 87/100.

Visit Ro

Compare with other providers

All 508 other providers we've reviewed, in our overall ranking order.

Every other program we track (502)

Pricing, states and verification reflect Ro's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Ro's site. Not medical advice; see our disclosure.

← Back to all rankings